RNAC Historical PE Ratio image   This RNAC PE ratio history page last updated 7/15/2024
RNAC Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/8/2024
23.25-10.50-42.00NA
Q4 2023
3/7/2024
19.32-41.70-166.80NA
Q3 2023
11/13/2023
26.43-1.80-7.20NA
Q2 2023
8/17/2023
33.60-0.07-0.28NA
Q1 2023
5/4/2023
32.10-0.14-0.56NA
Q4 2022
3/2/2023
47.400.040.16296.2
Q3 2022
11/3/2022
50.70-0.05-0.20NA
Q2 2022
8/4/2022
56.400.060.24235.0
Q1 2022
5/5/2022
24.300.080.3275.9
Q4 2021
3/10/2022
52.500.030.12437.5
Q3 2021
11/9/2021
115.50-0.16-0.64NA
Q2 2021
8/12/2021
131.100.000.00NA
Q1 2021
5/13/2021
87.90-0.22-0.88NA
Q4 2020
3/11/2021
117.00-0.14-0.56NA
Q3 2020
11/5/2020
97.20-0.09-0.36NA
Q2 2020
8/6/2020
75.60-0.25-1.00NA
Q1 2020
5/7/2020
90.00-0.21-0.84NA
Q4 2019
3/12/2020
62.40-0.28-1.12NA
Q3 2019
11/8/2019
41.70-0.26-1.04NA
Q2 2019
8/8/2019
53.40-0.37-1.48NA
Q1 2019
5/9/2019
72.00-0.31-1.24NA
Q4 2018
3/15/2019
65.10-0.65-2.60NA
Q3 2018
11/8/2018
173.85-0.71-2.84NA
Q2 2018
8/8/2018
390.60-0.84-3.36NA
Q1 2018
5/9/2018
320.10-0.71-2.84NA
Q4 2017
3/15/2018
273.90-0.88-3.52NA
Q3 2017
11/7/2017
310.80-0.66-2.64NA
Q2 2017
8/11/2017
470.10-0.85-3.40NA
Q1 2017
5/11/2017
405.30-0.82-3.28NA
Q4 2016
3/27/2017
357.60-0.77-3.08NA
Q3 2016
11/10/2016
620.40-0.43-1.72NA
Q2 2016
8/9/2016
330.30-2.75-11.00NA
RNAC PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/8/2024
23.25-10.50-54.07NA
Q4 2023
3/7/2024
19.32-41.70-43.71NA
Q3 2023
11/13/2023
26.43-1.80-1.97NA
Q2 2023
8/17/2023
33.60-0.07-0.22NA
Q1 2023
5/4/2023
32.10-0.14-0.09NA
Q4 2022
3/2/2023
47.400.040.13364.6
Q3 2022
11/3/2022
50.70-0.050.12422.5
Q2 2022
8/4/2022
56.400.060.01>500
Q1 2022
5/5/2022
24.300.08-0.05NA
Q4 2021
3/10/2022
52.500.03-0.35NA
Q3 2021
11/9/2021
115.50-0.16-0.52NA
Q2 2021
8/12/2021
131.100.00-0.45NA
Q1 2021
5/13/2021
87.90-0.22-0.70NA
Q4 2020
3/11/2021
117.00-0.14-0.69NA
Q3 2020
11/5/2020
97.20-0.09-0.83NA
Q2 2020
8/6/2020
75.60-0.25-1.00NA
Q1 2020
5/7/2020
90.00-0.21-1.12NA
Q4 2019
3/12/2020
62.40-0.28-1.22NA
Q3 2019
11/8/2019
41.70-0.26-1.59NA
Q2 2019
8/8/2019
53.40-0.37-2.04NA
Q1 2019
5/9/2019
72.00-0.31-2.51NA
Q4 2018
3/15/2019
65.10-0.65-2.91NA
Q3 2018
11/8/2018
173.85-0.71-3.14NA
Q2 2018
8/8/2018
390.60-0.84-3.09NA
Q1 2018
5/9/2018
320.10-0.71-3.10NA
Q4 2017
3/15/2018
273.90-0.88-3.21NA
Q3 2017
11/7/2017
310.80-0.66-3.10NA
Q2 2017
8/11/2017
470.10-0.85-2.87NA
Q1 2017
5/11/2017
405.30-0.82-4.77NA
Q4 2016
3/27/2017
357.60-0.77NANA
Q3 2016
11/10/2016
620.40-0.43NANA
Q2 2016
8/9/2016
330.30-2.75NANA
Quotes delayed 20 minutes

Email EnvelopeFree RNAC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cartesian Therapeutics (RNAC) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RNAZ PE Ratio History
RNXT PE Ratio History
RPHM PE Ratio History
RPID PE Ratio History
RPRX PE Ratio History
RSLS PE Ratio History
RUBY PE Ratio History
RVMD PE Ratio History
RVNC PE Ratio History
RVPH PE Ratio History
How should the RNAC historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Cartesian Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RNAC Historical PE Ratio page.

What is the average historical PE for RNAC based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RNAC historical PE ratio using the annualized quarterly earnings method works out to 261.1.

What is the average historical PE for RNAC based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RNAC historical PE ratio using the TTM earnings method works out to 393.6.

On this page we presented the RNAC Historical PE Ratio information for Cartesian Therapeutics' stock. The average RNAC historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 261.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RNAC historical PE based on this TTM earnings result method is 393.6. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RNAC historical PE result, against the recent PE: when this page was posted on 7/12/2024, the most recent closing price for RNAC had been 17.74, and the most recent quarterly earnings result, annualized, was 0.16. Meanwhile, the most recent TTM earnings summed to 0.13. From these numbers, we calculate the recent RNAC PE on 7/12/2024 based on annualized quarterly EPS was 110.9. Based on RNAC's history, that recent PE is low relative to the historical average, with the recent PE 57.5% lower than the historical average PE across our data set for Cartesian Therapeutics. Looking at the recent RNAC PE on 7/12/2024 based on TTM EPS, we calculate the ratio at 136.5. Based on RNAC's history, that recent PE is low relative to the historical average, with the recent PE 65.3% lower than the average PE across our Cartesian Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on RNAC or any other given stock, valuation analysis for RNAC can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cartesian Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RNAC. Thanks for visiting, and the next time you need to research RNAC Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: SAR Average Annual Return, LAZ YTD Return, JQC Insider Buying.

 

RNAC Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.